Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis

Cynthia S Crowson1,2, Silvia Rollefstad3, Eirik Ikdahl3

  • 1Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.

Insights

Rheumatoid arthritis (RA) patients face higher cardiovascular disease (CVD) risks. RA characteristics contribute to 30% of these CVD events, highlighting their importance in risk reduction strategies.

Area of Science:

  • Rheumatology
  • Cardiovascular Medicine
  • Epidemiology

Background:

  • Patients with rheumatoid arthritis (RA) exhibit an elevated risk of cardiovascular disease (CVD).
  • Understanding the specific contributions of traditional CVD risk factors and RA-specific variables is crucial for managing CVD in RA patients.
  • Potential sex differences in CVD risk require investigation within the RA population.

Purpose of the Study:

  • To assess the impact of cardiovascular disease (CVD) risk factors and rheumatoid arthritis (RA)-specific variables on CVD outcomes.
  • To investigate potential sex differences in the relationship between RA, CVD risk factors, and CVD outcomes.
  • To quantify the attributable risk of CVD events to both traditional risk factors and RA characteristics.

Main Methods:

  • A large, international cohort of 5638 RA patients without prior CVD was established across 13 rheumatology centers.
  • Baseline data on traditional CVD risk factors and RA characteristics were collected.
  • Standardized definitions were used to collect CVD outcomes during a mean follow-up of 5.8 years.

Main Results:

  • During follow-up, 148 men and 241 women experienced a CVD event, with higher 10-year cumulative incidence in men (20.9%) than women (11.1%).
  • Men presented a greater burden of CVD risk factors, including higher blood pressure, total cholesterol, and smoking prevalence.
  • Smoking and hypertension demonstrated the highest population attributable risk (PAR) among traditional factors, with RA Disease Activity Score and seropositivity showing comparable PAR to lipids.

Conclusions:

  • Rheumatoid arthritis (RA) characteristics account for 30% of cardiovascular disease (CVD) events in RA patients.
  • These RA-specific factors play a significant role in the elevated CVD risk observed in this population.
  • Targeting RA characteristics is essential for comprehensive CVD risk reduction strategies in patients with RA.
Abstract

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
605
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
748
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
370
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
408
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
607
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.3K